Keloids and hypertrophic scars

Dermatologic Surgery

Volumn 25, Issue 8, 1999, Pages 631-638

  English, Robert S ^a   Shenefelt, Philip D ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; RETINOID;

AUTOGRAFT; COLLAGEN SYNTHESIS; CRYOSURGERY; DRUG EFFECT; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC SCAR; KELOID; PREVALENCE; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

CICATRIX, HYPERTROPHIC; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; KELOID; RECURRENCE;

EID: 0032865642     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.1999.98257.x     Document Type: Review

References (90)

1. Murray JC. Scars and keloids. Dermatol Clin 1993;11:697-707.
2. Nemeth AJ. Keloids and hypertrophic scars. J Dermatol Surg Oncol 1993;19:738-46.
3. Murray JC, Pinnell SR. Keloids and excessive dermal scarring. In: Kelman Cohen I, Diegelmann RF, Lindblad WJ, eds. Wound healing; biochemical and clinical aspects. 1992:500-509.
4. Abrams BJ, Benedetto AV, Humeniuk HM. Exuberant keloidal formation. J AOAC Int 1993;93:863-5.
5. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars. A comprehensive review. Plast Reconstr Surg 1989;84:827-37.
6. Davies DM. Scars, hypertrophic scars and keloids. Plast Reconstr Surg 1985;290:1056-8.
7. Cosman B, Crikelair GF, Ju MC, Gaulin JC, Lattes R. The surgical treatment of keloids. Plast Reconstr Surg 1961;27:335-45.
8. Cohen IK, Peacock EE Jr. Keloids and hypertrophic scars. In:. Plastic Surgery, vol 1. 1990:732-46.
9. Stegman SJ, Tromovitch TA, Glogan RG. Treatment of keloids. In: Stegman SJ, eds. Cosmetic Dermatologic Surgery, 2nd ed. Chicago: Year Book Medical, 1990:201-6.
10. Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg 1992;118;63-7.
11. Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids. Plast Reconstr Surg 1974;53:140-53.
12. Kelly AP. Keloids. Dermatol Clin 1988;6:413-24.
13. Moustafa MRH, Abdel-Fattah MA. Presumptive evidence of the effect of pregnancy estrogens on keloid growth. Plast Reconstr Surg 1975;56:450-53.
14. Kazeem AA. The immunological aspects of keloid tumor formation. J Surg Oncol 1988;38:16-8.
15. Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scars. Am J Pathol 1994;145:105-13.
16. Rudolph R. Wide spread scars, hypertrophic scars and keloids. Clin Plast Surg 1987;14:253-60.
17. Nakaoka H, Miyauchi S, Miki Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Derm Venereol (Stockh) 1995;75:102-4.
18. Oliver N, Babu M, Diegelmann R. Fibronectin gene transcription is enhanced in abnormal wound healing. J Invest Dermatol 1992;99: 579-86.
19. Babu M, Dielgemann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989;9:1642-50.
20. Kokko LA, Rintala A, Savolainer ER. Collagen gene expression in keloids: analysis of collagen metabolism and type I III, IV, and V procollagen in RNA's in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 1987;89:238-44.
21. Abergel RP, Pizzurro D, Meeker C, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985;84:384-90.
22. Friedman DW, Boyd CD, MacKenzie JW, Norton P, Olson RM, Deak SB. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Research 1993;55:214-22.
23. Border WA, Noble NA. TGF-B. Sci Am Sci Med 1995;2:68-77.
24. Peltonen J, Hsiao LL, Jaakola S, et al. Activation of collagen gene expression in keloids: co-localization of type I and type VI collagen and transforming growth factor-B1 in RNA. J Invest Dermatol 1991;97:240-42.
25. Younai S, Ventors G, Vu S, Nichter L, Nimni M, Taun T. Role of growth factors in scar contraction: an in vitro analysis. Ann Plast Surg 1996;36:495-501.
26. Younai S, Nichter LJ, Wellitz T, et al. Modulation of collagen synthesis by TGF-B in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994;370:341-7.
27. Tan EML, Rouda S, Greenbaum SS, Moore JH Jr, Fox JW IV, Solberg S. Acidic and basic fibroblast growth factors down regulate collagen gene expression in keloid fibroblasts. Am J Pathol 1993; 142:463-70.
28. Kischer CW, Theis AC, Chuapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 1982;13:819-24.
29. Castagnoli C, Stella M, Magliacani G, Alasia ST, Richiardi P. Anomalous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury. Clin Exp Immunol 1990;82;350-54.
30. Castagnoli C, Peruccio D, Stella M, et al. The HLA-DRB 16 allogenotype constitutes a risk factor for hypertrophic scarring. Hum Immunol 1990;29:229-32.
31. Brown D. Keloids: a review of the literature. Br J Plast Surg 1990; 43:70-77.
32. Cohen IK, McCoy BJ, Mohanakumar T, Dielgelmann RF. Immunoglobin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 1979;63:689-95.
33. Kischer CW, Shetlar MR, Shetlar CL, Chrapil M. Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg 1983;71:821-5.
34. Placik OJ, Lewis VL Jr. Immunologic associations of keloids. Gynecol Obstet Surg 1992;175:185-93.
35. Lanza JT, Lucente FE, Har-el G. Keloid. Otolaryngol Head Neck Surg 1992;106:741-2.
36. Hendricks WM. Complications of ear piercing, treatment and prevention. Cutis 1991;48:386-93.
37. Zuber TJ, Dewitt DE. Earlobe keloids. Am Fam Physician 1994;49: 1835-41.
38. Babu M, Boi PR, Suguna L, Ramachandran K, Ramakrishnan KM. Differentiation of keloid and hypertrophic scar; correlation of the water proton relaxation times with the duration of the scar. Physiol Chem Phys Med NMR 1993;25:113-20.
39. Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol 1988;14:1275-6.
40. Borok TL, Bray M, Sinclair I, Plafker J, Labirth L, Rollins C. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys 1988;15:865-70.
41. Klumpar DI, Murray JC, Anscher M. Keloids treated with excisions followed by radiation therapy. J Am Acad Dermatol 1994;31: 225-31.
42. Darzi MA, Chowdri NA, Kaul SK, Kahn M. Evaluation of various methods of treating keloids and hypertrophic scars: 10 year follow-up study. Br J Plast Surg 1992;45:374-9.
43. Kovalie JJ, Perez CA. Radiation therapy following keloidectomy. A 20 year experience. Int J Radiat Oncol Biol Phys 1989;17:77-80.
44. Escarmant P, Zimmermann S, Amar A, et al. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys 1993;26:245-51.
45. Doornbos JF, Stoffel TJ, Hass AC, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys 1990;18:833-9.
46. Golladay ES. Treatment of keloids by single intraoperative perilesional injection of repository steroid. South Med J 1988;81:736-8.
47. Low SQ, Moy RL. Scar war strategies. Target collagen. J Dermatol Surg Oncol 1992;18:981-6.
48. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol 1993;19:529-34.
49. Zouboulis CC, Blume U, Buttner P, Orfanos CE. Outcomes of cryosurgery in keloids and hypertrophic scars. Arch Dermatol 1993; 129:1146-51.
50. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 1994;130:498-501.
51. Gold MH. Topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Dermatol Surg Oncol 1993;19:912-6.
52. Nathan C, Yoshioia R. Cytokines: interferons and inflammation. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation. Basic principles and clinical correlates. New York: Raven Press, 1988: 241-51.
53. Chang CC, Kuo YF, Hsien-Ching C, Lee JL, Wong TW, Jee SH. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res 1995;59:705-11.
54. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994;30:506-7.
55. Ahn ST, Monafo WW, Mustoc TA. Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch Surg 1991;126: 499-504.
56. Fulton JE. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg 1995;21: 947-51.
57. Palmieri B, Gozzi G, Palmieri G. Vitamin E added silicone gel sheets for treatment of hypertrophic scars and keloids. Int J Dermatol 1995;34:506-9.
58. Davies DM. Scars, hypertrophic scars and keloids. Br Med J 1985; 290:1056-8.
59. Baur PS, Larson DL, Stacey TR, Barratt GJ, Dobrkovsky M. Ultrastructural analysis of pressure treated human hypertrophic scars. J Trauma 1976;16:958-67.
60. Ahn ST, Mustoe TA, Monafo WW. Topical silicone gel: a new treatment for hypertrophic scars. Surgery 1989;106:781-7.
61. Grimes PE, Hunt SG. Considerations for cosmetic surgery in the black population. Clin Plast Surg 1993;20:27-34.
62. Brown LA, Pierce HE. Keloids. Scar revision. J Dermatol Surg Oncol 1986;12:51-6.
63. Zitelli JA, Moy RL. The buried vertical mattress suture. J Dermatol Surg Oncol 1989;15:17-9.
64. Salasche SJ, Grabski WJ. Keloids of the earlobes: a surgical technique. J Dermatol Surg Oncol 1983;9:552-6.
65. Henderson DL. Discussion: the effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg 1991;1:50-53.
66. Tang YW. Intra-and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg 1992;45:371-3.
67. Kauh YC, Rouda S, Mondragon G, et al. Major suppression of pro-alpha 1 (I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 1997;37:586-9.
68. Sherris DA, Larabee WF, Murakami CS. Management of scar contractures, hypertrophic scars and keloids. Otolaryngol Clin 1995; 34:506-9.
69. Borges AF. The W-plasty versus the Z-plasty scar revision. Plast Reconstr Surg 1969;44:58-62.
70. Engrav LH, Walkinshaw MS, Heimbach DM, et al. A comparison of intramarginal and extramarginal excision of hypertrophic burn scars. Plast Reconstr Surg 1988;81:40-43.
71. Apfelberg DB, Maser MR, White DN, Lash H. Failure of carbon dioxide laser excision of keloids. Lasers Surg Med 1989;9:382-8.
72. Norris JEC. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg 1991;87:44-53.
73. Lim TC, Tan WT. Carbon dioxide laser for keloids. Plast Reconstr Surg 1991;88:1111.
74. Stern JC, Lucente FE. Carbon dioxide laser excision of earlobe keloids. Arch Otolaryngol Head Neck Surg 1989;115:1107-11.
75. Alster TS. Laser treatment of hypertrophic scars, keloids and striae. Dermatol Clin 1997;15:419-29.
76. Alster TS. Improvement of erythematous and hypertrophic scars by the 585 nm flashlamp-pumped pulse dye laser. Ann Plast Surg 1994;32:186-90.
77. Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg 1995;21:685-7.
78. Pittet B, Rubbia-Brandt L, Desmouliere A, et al. Effect of Y-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast Reconstr Surg 1994;93:1224-35.
79. Granstein RD, Rook A, Flotte TJ, et al. A controlled trial of intralesional recombinant interferon-Y in the treatment of keloidal scarring. Arch Dermatol 1990;126:1295-302.
80. Berman B, Duncan MR. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma, and morphea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol 1990;123:339-46.
81. Berman B, Duncan MR. Pentoxifylline inhibits human keloid and scleroderma dermal fibroblast in vitro proliferation and collagen glycosaminoglycan and fibronectin production. Clin Res 1989;37: A348.
82. Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg 1996;22:126-30.
83. Berman B, Bieley HC. Keloids. J Am Acad Dermatol 1995;33:117-23.
84. Waki EY, Crumley RL, Jakowatz JG. Effects of pharmacologic agents on human keloids implanted in athymic mice. Otolaryngol Head Neck Surg 1991;117:1177-81.
85. Chrapil M, Peacock E, Carlson ES, Blau S, Steinbronn K, Morton D. Colchine and wound healing. J Surg Res 1980;28:49-56.
86. Lee R, Ping J. Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J Surg Res 1990;49:463-6.
87. Lee RC, Doong H, Jellem AF. The response of burn scars to intralesional verapamil. Report of 5 cases. Arch Surg 1994;129:107-11.
88. Suzawa H, Kibuchi S, Arai N, Koda A. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 1992;60:91-6.
89. Edgerton MT, Hahrahan EM, Davis WB. Use of vitamin E in the treatment of keloids. Plast Reconstr Surg 1951;8:224-33.
90. Haas AF, Reilly DA. Cultured epithelial autografts in the treatment of extensive recalcitrant keloids. Arch Dermatol 1998;134:549-52.